eGenesis, a biotechnology company, is working to develop a solution to the organ transplant shortage. The company aims to create human-compatible organs (HuCo™) using gene editing technology to overcome challenges associated with xenotransplantation (transplantation of organs from animals to humans). They cite alarming statistics about the growing number of people needing transplants and the limited supply of human donor organs. eGenesis's approach focuses on engineering hope for those on transplant waitlists by potentially providing a reliable and abundant source of organs.
Podcast creator page: http://santarovich.tilda.ws/
